APA
Solmone M., Giombini E., Vincenti D., Rozera G., Testa A., Moscetti A., Catalano M., Abbate I., Capobianchi M. R. & Menzo S. (20141203). Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants. : Antiviral therapy.
Chicago
Solmone Mariacarmela, Giombini Emanuela, Vincenti Donatella, Rozera Gabriella, Testa Angela, Moscetti Alessandra, Catalano Manuela, Abbate Isabella, Capobianchi Maria R and Menzo Stefano. 20141203. Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants. : Antiviral therapy.
Harvard
Solmone M., Giombini E., Vincenti D., Rozera G., Testa A., Moscetti A., Catalano M., Abbate I., Capobianchi M. R. and Menzo S. (20141203). Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants. : Antiviral therapy.
MLA
Solmone Mariacarmela, Giombini Emanuela, Vincenti Donatella, Rozera Gabriella, Testa Angela, Moscetti Alessandra, Catalano Manuela, Abbate Isabella, Capobianchi Maria R and Menzo Stefano. Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants. : Antiviral therapy. 20141203.